Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Urol. 2008 Oct;180(4):1336-9; discussion 1340-1. doi: 10.1016/j.juro.2008.06.027. Epub 2008 Aug 15.

Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era.

Author information

  • 1Division of Urology, University of Connecticut Health Center, Farmington, Connecticut 06030-3955, USA.

Abstract

PURPOSE:

We gained insights concerning outcomes associated with men who elect active surveillance for the management of localized prostate cancer.

MATERIALS AND METHODS:

This is a retrospective case series analysis of 40 patients diagnosed with localized prostate cancer since 1990 who elected active surveillance.

RESULTS:

A total of 31 patients remained on active surveillance for a median of 48 months (range 12 to 168). The 5-year probability of remaining on active surveillance was 74%. Most patients who abandoned this strategy did so within 33 months of diagnosis (range 12 to 84). An increasing prostate specific antigen and anxiety were the 2 most common reasons. A delay in treatment did not appear to compromise subsequent outcomes.

CONCLUSIONS:

Men with low grade prostate cancer can elect active surveillance and have excellent long-term results.

Comment in

PMID:
18707696
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk